Artificial Intelligence Can Predict Cancer Survival Using Data From a Single Consultation
Artificial intelligence can predict survival in cancer patients using information from a patient’s initial consultation with an oncologist, a study suggests.
Diagnosis & Disease Information
Investigational Therapy Gets Fast Track Status for Glioblastoma Multiforme
In mouse models, WP1122 outperformed temozolomide.
Convection-Enhanced Delivery of Topotecan Active in Glioblastoma
Chronic convection-enhanced delivery of topotecan was feasible and well tolerated in patients with recurrent glioblastoma.
Dendritic Cell Vaccine Improves Upon Standard Care for Glioblastoma
Adding an autologous tumor lysate-loaded dendritic cell vaccine to standard care improves survival in patients with glioblastoma, a phase 3 study suggests.
Most Phase 3 Trials of Newly Diagnosed Glioblastoma Show No Improvement in OS
Most recent phase 3 trials of patients with newly diagnosed glioblastoma have shown no significant improvement in overall survival with the experimental treatment.
Deaths on the Rise in Patients With Malignant Brain Tumors
Deaths among patients with primary malignant brain tumors are on the rise in the United States, data suggest.
Predicting Outcomes of Regorafenib in Patients With Recurrent Glioblastoma
Researchers say they have identified a molecular signature that can be used to predict outcomes of regorafenib treatment in patients with recurrent glioblastoma.
Women With Glioblastoma May Be More Likely to Benefit From Immunotherapy
Among glioblastoma patients, women may derive more benefit from immunotherapy than men, research suggests.
Novel Agent Plus Radiotherapy Shows Promise in MGMT-Unmethylated Glioblastoma
VAL-083 in combination with radiotherapy is safe and active in patients with newly diagnosed MGMT-unmethylated glioblastoma, a phase 2 trial suggests.
Sequence of Ondansetron and Rolapitant Does Not Impact Efficacy in Malignant Glioma
The sequence of treatment with rolapitant and ondansetron does not appear to impact chemoradiation-induced nausea and vomiting.
- Loading...
Loading...
Next post in SNO 2022
Loading... 
Loading...